{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:09:52Z","timestamp":1776442192356,"version":"3.51.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T00:00:00Z","timestamp":1206057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00247-008-0764-6","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T08:39:37Z","timestamp":1206002377000},"page":"529-537","source":"Crossref","is-referenced-by-count":32,"title":["MR imaging of ovarian tumors using folate-receptor-targeted contrast agents"],"prefix":"10.1007","volume":"38","author":[{"given":"Zhen J.","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Boddington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wendland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Corot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Daldrup-Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,21]]},"reference":[{"key":"764_CR1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0083-6729(03)01012-4","volume":"66","author":"LH Matherly","year":"2003","unstructured":"Matherly LH, Goldman DI (2003) Membrane transport of folates. Vitam Horm 66:403\u2013456","journal-title":"Vitam Horm"},{"key":"764_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10555-007-9048-0","volume":"26","author":"MD Salazar","year":"2007","unstructured":"Salazar MD, Ratnam M (2007) The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev 26:141\u2013152","journal-title":"Cancer Metastasis Rev"},{"key":"764_CR3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0304-4165(86)90253-9","volume":"882","author":"E Sadasivan","year":"1986","unstructured":"Sadasivan E, Rothenberg SP, da Costa M et al (1986) Characterization of multiple forms of folate-binding protein from human leukemia cells. Biochim Biophys Acta 882:311\u2013321","journal-title":"Biochim Biophys Acta"},{"key":"764_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.nu.16.070196.002441","volume":"16","author":"AC Antony","year":"1996","unstructured":"Antony AC (1996) Folate receptors. Annu Rev Nutr 16:501\u2013521","journal-title":"Annu Rev Nutr"},{"key":"764_CR5","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S","volume":"73","author":"JF Ross","year":"1994","unstructured":"Ross JF, Chaudhuri PK, Ratnam M (1994) Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73:2432\u20132443","journal-title":"Cancer"},{"key":"764_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F","volume":"74","author":"G Toffoli","year":"1997","unstructured":"Toffoli G, Cernigoi C, Russo A et al (1997) Overexpression of folate binding protein in ovarian cancers. Int J Cancer 74:193\u2013198","journal-title":"Int J Cancer"},{"key":"764_CR7","first-page":"3396","volume":"52","author":"SD Weitman","year":"1992","unstructured":"Weitman SD, Lark RH, Coney LR et al (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52:3396\u20133401","journal-title":"Cancer Res"},{"key":"764_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1005713115147","volume":"32","author":"TA Patrick","year":"1997","unstructured":"Patrick TA, Kranz DM, van Dyke TA et al (1997) Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice. J Neurooncol 32:111\u2013123","journal-title":"J Neurooncol"},{"key":"764_CR9","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1158\/1078-0432.CCR-06-1343","volume":"13","author":"R Yang","year":"2007","unstructured":"Yang R, Kolb EA, Qin J et al (2007) The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate. Clin Cancer Res 13:2557\u20132567","journal-title":"Clin Cancer Res"},{"key":"764_CR10","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1182\/blood.V96.10.3529","volume":"96","author":"H Wang","year":"2000","unstructured":"Wang H, Zheng X, Behm FG et al (2000) Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia. Blood 96:3529\u20133536","journal-title":"Blood"},{"key":"764_CR11","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/bi00171a021","volume":"33","author":"F Shen","year":"1994","unstructured":"Shen F, Ross JF, Wang X et al (1994) Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry 33:1209\u20131215","journal-title":"Biochemistry"},{"key":"764_CR12","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1182\/blood.V79.11.2807.2807","volume":"79","author":"AC Antony","year":"1992","unstructured":"Antony AC (1992) The biological chemistry of folate receptors. Blood 79:2807\u20132820","journal-title":"Blood"},{"key":"764_CR13","first-page":"1153","volume":"47","author":"A Bettio","year":"2006","unstructured":"Bettio A, Honer M, Muller C et al (2006) Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors. J Nucl Med 47:1153\u20131160","journal-title":"J Nucl Med"},{"key":"764_CR14","first-page":"857","volume":"45","author":"JA Reddy","year":"2004","unstructured":"Reddy JA, Xu LC, Parker N et al (2004) Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors. J Nucl Med 45:857\u2013866","journal-title":"J Nucl Med"},{"key":"764_CR15","first-page":"1563","volume":"40","author":"W Guo","year":"1999","unstructured":"Guo W, Hinkle GH, Lee RJ (1999) 99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging. J Nucl Med 40:1563\u20131569","journal-title":"J Nucl Med"},{"key":"764_CR16","first-page":"1579","volume":"39","author":"CJ Mathias","year":"1998","unstructured":"Mathias CJ, Wang S, Waters DJ et al (1998) Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J Nucl Med 39:1579\u20131585","journal-title":"J Nucl Med"},{"key":"764_CR17","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1021\/ja043006n","volume":"127","author":"CY Ke","year":"2005","unstructured":"Ke CY, Mathias CJ, Green MA (2005) Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid. J Am Chem Soc 127:7421\u20137426","journal-title":"J Am Chem Soc"},{"key":"764_CR18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/bc0200430","volume":"13","author":"CP Leamon","year":"2002","unstructured":"Leamon CP, Parker MA, Vlahov IR et al (2002) Synthesis and biological evaluation of EC20: a new folate-derived, (99\u00a0m)Tc-based radiopharmaceutical. Bioconjug Chem 13:1200\u20131210","journal-title":"Bioconjug Chem"},{"key":"764_CR19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00259-006-0111-9","volume":"33","author":"C Muller","year":"2006","unstructured":"Muller C, Hohn A, Schubiger PA et al (2006) Preclinical evaluation of novel organometallic 99\u00a0mTc-folate and 99\u00a0mTc-pteroate radiotracers for folate receptor-positive tumour targeting. Eur J Nucl Med Mol Imaging 33:1007\u20131016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"764_CR20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/cbr.2006.21.49","volume":"21","author":"SM Okarvi","year":"2006","unstructured":"Okarvi SM, Jammaz IA (2006) Preparation and in vitro and in vivo evaluation of technetium-99m-labeled folate and methotrexate conjugates as tumor imaging agents. Cancer Biother Radiopharm 21:49\u201360","journal-title":"Cancer Biother Radiopharm"},{"key":"764_CR21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1021\/bc0340114","volume":"14","author":"WK Moon","year":"2003","unstructured":"Moon WK, Lin Y, O\u2019Loughlin T et al (2003) Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjug Chem 14:539\u2013545","journal-title":"Bioconjug Chem"},{"key":"764_CR22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1117\/1.1609453","volume":"8","author":"MD Kennedy","year":"2003","unstructured":"Kennedy MD, Jallad KN, Thompson DH et al (2003) Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. J Biomed Opt 8:636\u2013641","journal-title":"J Biomed Opt"},{"key":"764_CR23","first-page":"67","volume":"4","author":"WT Chen","year":"2005","unstructured":"Chen WT, Khazaie K, Zhang G et al (2005) Detection of dysplastic intestinal adenomas using a fluorescent folate imaging probe. Mol Imaging 4:67\u201374","journal-title":"Mol Imaging"},{"key":"764_CR24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004424-200001000-00006","volume":"35","author":"SD Konda","year":"2000","unstructured":"Konda SD, Aref M, Brechbiel M et al (2000) Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress. Invest Radiol 35:50\u201357","journal-title":"Invest Radiol"},{"key":"764_CR25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF02668091","volume":"12","author":"SD Konda","year":"2001","unstructured":"Konda SD, Aref M, Wang S et al (2001) Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. MAGMA 12:104\u2013113","journal-title":"MAGMA"},{"issue":"2","key":"764_CR26","doi-asserted-by":"crossref","first-page":"S316","DOI":"10.1016\/S1076-6332(03)80215-5","volume":"9","author":"EC Wiener","year":"2002","unstructured":"Wiener EC, Konda SD, Wang S et al (2002) Imaging folate binding protein expression with MRI. Acad Radiol 9(Suppl 2):S316\u2013S319","journal-title":"Acad Radiol"},{"key":"764_CR27","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.acra.2004.04.018","volume":"11","author":"H Choi","year":"2004","unstructured":"Choi H, Choi SR, Zhou R et al (2004) Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 11:996\u20131004","journal-title":"Acad Radiol"},{"key":"764_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cmmi.128","volume":"2","author":"O Saborowski","year":"2007","unstructured":"Saborowski O, Simon GH, Raatschen HJ et al (2007) MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent. Contrast Media Mol Imaging 2:72\u201381","journal-title":"Contrast Media Mol Imaging"},{"key":"764_CR29","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/mol.104.003723","volume":"66","author":"CM Paulos","year":"2004","unstructured":"Paulos CM, Reddy JA, Leamon CP et al (2004) Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery. Mol Pharmacol 66:1406\u20131414","journal-title":"Mol Pharmacol"},{"key":"764_CR30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/1439-7633(20020802)3:8<784::AID-CBIC784>3.0.CO;2-X","volume":"3","author":"CH Tung","year":"2002","unstructured":"Tung CH, Lin Y, Moon WK et al (2002) A receptor-targeted near-infrared fluorescence probe for in vivo tumor imaging. Chembiochem 3:784\u2013786","journal-title":"Chembiochem"},{"key":"764_CR31","first-page":"56","volume":"39","author":"I Raynal","year":"2004","unstructured":"Raynal I, Prigent P, Peyramaure S et al (2004) Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 39:56\u201363","journal-title":"IR"},{"key":"764_CR32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00004424-199712000-00005","volume":"32","author":"EC Wiener","year":"1997","unstructured":"Wiener EC, Konda S, Shadron A et al (1997) Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor. Invest Radiol 32:748\u2013754","journal-title":"Invest Radiol"},{"key":"764_CR33","unstructured":"Corot C, Lancelot E, Prigent P, Port M (2005) Tumor imaging using a high relaxivity gadolinium chelate targeted to the folate receptor. Proceedings of the 13th Scientific Meeting of the International Society of Magnetic Resonance in Medicine, Miami, FL, p 2601"},{"key":"764_CR34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/(SICI)1097-4644(19970615)65:4<479::AID-JCB4>3.0.CO;2-L","volume":"65","author":"S Miotti","year":"1997","unstructured":"Miotti S, Bagnoli M, Ottone F et al (1997) Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines. J Cell Biochem 65:479\u2013491","journal-title":"J Cell Biochem"},{"key":"764_CR35","first-page":"60","volume-title":"Molecular and cellular MR imaging","author":"C Corot","year":"2007","unstructured":"Corot C, Guilbert I, Robert P, Raynal I, Robic C, Raynaud JS, Prigent P, Dencausse A, Idee JM (2007) Superparamagnetic contrast agents. In: Modo MM, Bulte JW (eds) Molecular and cellular MR imaging. CRC Press, Boca Raton, pp 60\u201383"},{"key":"764_CR36","first-page":"775","volume":"8","author":"M Wu","year":"1999","unstructured":"Wu M, Gunning W, Ratnam M (1999) Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. Cancer EpidemiolBiomarkers Prev 8:775\u2013782","journal-title":"Cancer EpidemiolBiomarkers Prev"},{"key":"764_CR37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jcp.48.7.631","volume":"48","author":"MR Buist","year":"1995","unstructured":"Buist MR, Molthoff CF, Kenemans P et al (1995) Distribution of OV-TL3 and MOv18 in normal and malignant ovarian tissue. J Clin Pathol 48:631\u2013636","journal-title":"J Clin Pathol"},{"key":"764_CR38","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/sj.gt.3301962","volume":"10","author":"M Figini","year":"2003","unstructured":"Figini M, Ferri R, Mezzanzanica D et al (2003) Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti-folate receptor antibodies. Gene Ther 10:1018\u20131025","journal-title":"Gene Ther"},{"key":"764_CR39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<121::AID-IJC4>3.0.CO;2-V","volume":"79","author":"G Toffoli","year":"1998","unstructured":"Toffoli G, Russo A, Gallo A et al (1998) Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer. Int J Cancer 79:121\u2013126","journal-title":"Int J Cancer"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-008-0764-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00247-008-0764-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-008-0764-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T07:49:49Z","timestamp":1588492189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00247-008-0764-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,21]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["764"],"URL":"https:\/\/doi.org\/10.1007\/s00247-008-0764-6","relation":{},"ISSN":["0301-0449","1432-1998"],"issn-type":[{"value":"0301-0449","type":"print"},{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,21]]}}}